BACKGROUND. Merkel cell carcinoma is an uncommon malignant tumor of the skin that, after standard surgical excision, tends to recur locally and develop regional nodal spread. oB]ECTrvE. This study evaluated the use of Mohs micrographic surgery for this aggressive neoplasm. METHODS. A retrospective study of 86 patients with Merkel cell carcinoma established rates of local persistence and the development of regional metastasis after standard surgical excision. Detailed follow-up was availake on a subgroup of 13 patients treated with Mohs surgery. RESULTS. Standard surgical excision for local disease was associated with high rates of local persistence (13 of 41 [31.7%]) and regional metastasis (20 of 41 148.8%]). Mean follow-up was 60 months. Mean follow-up for the group treated with Mohs was 36 months. Only one of 12 (8.3%) Mohs-treated patients with histologically confirmed clearance has had local persistence of disease. This patient underwent a second Mohs excision and has remained disease free for 84 months. Regional metastasis developed in four of 12 cases (33.3%). Regional metastasis developed in none of the four patients treated with radiotherapy after Mohs surgery and in four of eight patients treated with Mohs surgery without postoperative radiotherapy. CONCLUSION. Mohs surgery compares favorably with standard surgical excision. Radiotherapy after Mohs surgery may further reduce persistent metastases in transit and nodal disease.
M erkel cell carcinoma (MCC) was first described by Toker in 1972 .' Despite its irmocuous clinical features (Figure 1) , it is an aggressive malignancy with a poor prognosis. Local persistence occurs in 26-44"4 of surgically treated patients. Multiple reexcisions are often required. Regional nodal metastases may occur in up to 75% of patients. The overall 5-year survival is poor (30-64%). ' Histologically, the tumor is composed of anastomosing cords (trabeculae) of undifferentiated small cells that may infiltrate deeply into the dermis and subcutis ( Figure 2 ). Abundant mitoses, foci of tumor necrosis, and vascular and lymphatic invasion may be seen. Immunohistochemistry reveals positive staining with neuron-specific enolase of low molecular weight cytokeratin in a paranuclear location. Paranuclear staining with neurofilament is seen, which is absent in normal Merkel cells. Staining for the neurosecretory granule synaptophysin may also be positive. With electron microscopy, cells of MCC closely resemble normal Merkel cells. Spherical cytoplasmic membrane-bound core granules surrounded by a clear halo may be seen by electron microscopy.^O wing to the rarity of the tumor, treatm.ent re-com^mendations are largely based on individual cases and small series. The current standard of care is wide excision with 2.5-3-cm margins and resection of any palpable regional hTnph nodes. Elective lymph node resection remains controversial.* Radiation of the postsurgical bed and lymph node basin has been shown to be of benefit in decreasing local and nodal persistence of disease.''
Materials and Methods
We retrospectively reviewed the Mayo Clinic experience with MCC. From 1975 to 1995, 86 cases were seen at three Mayo Clinic sites: Rochester, MN; Jacksonville, FL; and Scottsdale, AZ. Patient age at disease onset, sex, site of tumor, stage at presentation, treatment received, duration of follow-up, and recurrence were noted. Detailed follow-up was available on a subgroup of 13 patients treated with Mohs surgery. The persistence rates and duration of follow-up were compared for the two treatment groups, which were of similar age and sex distribution. Erythematous nodule on upper back. Biopsy showed ental) were white. Mean age at diagnosis was 67 years for men and 68 years for women.
The most frequent site of MCC at presentation was the head and neck region with 41 cases (48%) of tumors. Of these 41 head and neck tumors, 20 occurred over the cheeks or forehead. Other sites included the trunk (8), buttock (11) , upper extremities (12) , and lower extremities (14) .
At diagnosis, 62 patients (72%) presented with local disease, 18 (21%) with clinically apparent disease in regional lymph nodes, and 6 (7%) with distant metastases.
Of the 86 patients, 50 patients were treated with surgery alone; seven were treated with a combination of surgery and radiotherapy; 13 with surgery and chemotherapy; and 13 with surgery, chemotherapy, and radiotherapy. Of the patients treated surgically, 13 patients were treated with Mohs micrographic surgery. These patients were of similar age and sex distribution. Mohs surgery was the only therapy in nine of these patients.
Forty-one patients with clinically local disease underwent standard surgical excision. None of these patients received adjuvant therapy. In these patients local persistence (defined as disease nonadjacent to the scar) and regional metastasis were common, occurring in 13 of 41 (32%) and 20 of 41 (49%), respectively, at a mean follow-up of 60 months. Nineteen of 73 patients (26%) treated with standard wide excision died of metastatic disease. Table 1 details age, sex, tumor site, any radiation treatment received, disease persistence, and duration of follow-up for 13 patients who had MCC treated with Mohs surgery.
The mean preoperative tumor size (largest diameter) for the Mohs-treated group was 2.98 cm (range, 9-9.2 cm). Tumors in the wide-excision group were smaller (average, 1.57 cm; range, 4-4.5 cm).
Only one patient treated with Mohs surgery with histologically confirmed clearance has thus far shown evidence of locally persistent disease. The patient had a second Mohs excision and has remained disease free for 84 months.
Duration of F/U (months)
The four patients treated with Mohs surgery and radiotherapy remain disease free at a mean follow-up of 2 years, whereas four of eight patients who had Mohs surgery without radiotherapy developed regional metastases.
Patient 13 has not been included in the foUow-up data. He had an MCC of the upper chest ( Figure 3 ). After seven stages of Mohs surgery, histologic clearance was not achieved. Disease was found extending into the pretracheal fascia ( Figure 3B ). The patient had further resection of the paratracheal disease but died of widely metastatic disease 12 weeks later. Table 2 details the preoperative and postoperative defect size, the number of staged excisions, and the method of repair. It is the policy of one of the surgeons contributing to this series to take an additional 5-10-mm margin beyond histologic clearance where this is cosmetically possible. Any additional margin taken is noted in Table 2 .
Discussion
This is among the largest series of MCCs reviewed to date. In agreement with previous studies, standard surgical excision was associated with high rates of local persistence and regional metastasis, 32% and 49%, respectively. Early aggressive therapy is indicated in the treatment of this tumor because of its significant mortality rates. The present standard of care involves surgical excision with 2.5-3-cm margins plus dissection of clinically apparent regional hinph nodes.*'"'' However, 10% of MCC occur in the periocular region and are not amenable to wide surgical margins.'" Mohs surgery has been used to treat MCC,''"'' but long-term outcome studies are not available. Mohs surgery might be expected to have potential advantages in a tumor that is locally invasive and locally persistent, has clinically indistinct margins, and is amenable to examination by frozen sections." Tissue conser\'ation might be an added benefit on the head and neck area where the majority of these tumors occur. Mohs for MCC on a digit may limit the need for amputation. Preservation of normal structure and function of important anatomic structures and decreased need for future treatment of the same tumor, with improved cost effectiveness, are further advantages. A single local persistence in one of 12 Mohs-treated cases and regional nodal metastasis in four of 12 cases at mean follow-up of 36 months (range, 6-86 months) compares favorably with the outcome of patients treated with "wide" excision.
Concern has been expressed that MCC may spread in a noncontiguous fashion and thus would not be suitable for Mohs. The excellent local control of disease obser\'ed in the patients studied herein, however, suggests that the tumor remains contiguous at least initially. With further disease progression, the tumor m^ay become noncontiguous, but this should not lessen efforts at local disease control. It is also possible that tumors labeled as noncontiguous MCC may in fact represent metastatic oat cell carcinoma. Figure 4 shows multiple scalp nodules in a patient that were labeled as MCC. Work-up revealed primary oat cell carcinoma of lung. These tumors will have the same histologic and immunohistochemical appearance as MCC, emphasizing the need for a detailed w^ork-up to eliminate the possibility of an occult lung primary, especially in a smoker.
Patient 13 in this study ( Figure 3A and B) emphasizes the aggressive growth pattern of MCC. After seven stages of Mohs surgery, tumor-free margins were still not achieved and disease was found extending into the pretracheal fascia. Purther surgery was performed in an attempt to clear the tumor, but the patient died 3 months later. It is necessary to maintain a multidisciplinary approach in the treatment of this tumor, involving radiotherapists, oncologists, and appropriate surgical specialists. It is the practice of some surgeons to take an additional 5-10-mm margin beyond histologic clearance in primary tumor sites where tissue conservation is not a prime concern.
Radiotherapy to the surgical bed and nodal basin has also been recommended. In a large series of 80 patients treated at the Queensland Radium Institute, all 38 patients treated with surgery alone relapsed within a median of 5.5 months. Only 10 of 34 patients treated with surgery and radiotherapy relapsed, with a median time to relapse of 16.5 months.'' There was a trend for the Mohs-treated tumors in this study with larger postoperative defects to be associated with local persistence and regional metastasis. These patients should certainly receive postoperative radiation therapy.
While local persistence may be reduced by Mohs, much of the morbidity and mortality is related to inadequate disease control in regional nodes. Mohs surgery will not have any effect in cases with occult in transit or nodal metastases. Postoperative radiotherapy has been proven to reduce the high incidence of regional metastasis and should be strongly considered in the management of these patients.^''* Local persistence of MCC is usually seen clinicaDy at a mean of 4 months and nodal metastases at 7-8 months.^ The mean follow-up duration of 36 months for the Mohs-treated patients in this study thus appears valid. Although longer follow-up of larger series of patients treated with Mohs is necessary, it appears that outcomes after Mohs surgery compare favorably with those of standard surgical excision.
